Interventions to reduce HIV transmission related to injecting drug use in prison

Jürgens, Ralf; Ball, Andrew; Verster, Annette

doi:10.1016/s1473-3099(08)70305-0

Cited by 177 publications

(160 citation statements)

References 61 publications

Supporting

Mentioning

153

Contrasting

Unclassified

Order By: Relevance

“…In this perspective, injecting drug users (IDUs) are the main interest group for the prevention of their transmission within prisons, since most of these users have already been arrested at some point in their lives. Similar data was found between researchers 14 in which more than half and up to 90% of drug users have ever had an episode of incarceration.…”

supporting

confidence: 85%

Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa

Araújo

Pinheiro

Souza

2017

R. pesq. cuid. fundam. online

View full text Add to dashboard Cite

Hepatitis C and associated risks in prisons: an integrative reviewHepatite C e riscos associados em presídios: uma revisão integrativa Hepatitis C y riesgos asociados en las cárceles: una revisión integradora ABSTRACTObjective: To assess the current scientific literature on the prevalence of hepatitis C and associated risks in prisons. Method: This is an integrative review conducted in the Web of Science, Cumulative Index to Nursing and Allied Health Literature (CINAHL) and Literature in the Health Sciences in Latin America and the Caribbean (LILACS in Portuguese) databases, including articles published between 2009 and 2014. Based on the inclusion and exclusion criteria, we selected 16 articles. Results: Descriptive (37.5%) and transverse (50%) articles predominated. All of them had level IV of scientific evidence. The prevalence of Hepatitis C was varied and the main risk factors associated with positive results for hepatitis C were injecting drug use, tattooing and age. Conclusion: Being a long-haul asymptomatic disease, hepatitis C is revealed as a major problem in the prison system, requiring more attention in order to produce knowledge to guide the adoption of effective measures for control and prevention. Descriptors: Hepatitis C; Prevalence; Prisons; Risk factors. (37,5%), transversais (50%). Todos apresentaram nível IV de evidência científica. A prevalência de hepatite C foi variada, e os principais fatores de risco associados à positividade para hepatite C foram o uso de drogas injetáveis, presença de tatuagem, idade. Conclusão: Por ser uma doença de longo curso assintomático, a hepatite C apresenta-se como um problema relevante no sistema prisional, exigindo mais atenção no sentido de produzir conhecimentos, que orientem a adoção de medidas efetivas de controle e prevenção. Descritores: Hepatite C, Prevalência, Prisões, Fatores de risco. La prevalencia de la hepatitis C se varió y los principales factores de riesgo asociados fueron consumo de drogas intravenosas, los tatuajes, la edad. Conclusión: Al ser una enfermedad asintomática de largo recorrido, la hepatitis C se revela como un problema en el sistema penitenciario, lo que requiere más atención con el fin de producir conocimiento para guiar la adopción de medidas eficaces de control y prevención.

show abstract

supporting

confidence: 85%

Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa

Araújo

Pinheiro

Souza

2017

R. pesq. cuid. fundam. online

View full text Add to dashboard Cite

show abstract

“…16 A more recent review reported a range of 2% to 74% of prisoners injecting while inside prison; however, the majority of studies report between 10% and 30% of injecting practices inside prison. 17 Though literature from prisoners in developing or economically transitional countries is scarce, a study in Thailand shows that up to a quarter of male inmates in Bangkok reported injecting during incarceration. IDU injecting drug user, CI confidence interval taking account of cluster effect, SE standard error of the mean Importantly, most of the injecting practices inside this prison were reported to have been done using handmade and mainly shared injecting tools.…”

Section: Discussionmentioning

confidence: 99%

Patterns of Drug Use and HIV-Related Risk Behaviors among Incarcerated People in a Prison in Iran

Zamani

Farnia²,

Torknejad³

et al. 2010

J Urban Health

View full text Add to dashboard Cite

Previous research indicates that prisoners in Iran are at risk of drug-related harm, including acquisition of blood-borne infections. In response, several prevention interventions have been introduced into prisons in Iran, such as methadone maintenance treatment (MMT). MMT is now provided to opioid-dependent prisoners in 142 of the 230 prisons and correctional settings in Iran. A baseline behavioral survey was conducted in Karaj Central prison which mainly holds prisoners with drug-related charges. Overall, 203 male prisoners from randomly selected rooms in two prison blocks were interviewed using a structured questionnaire in 2007, just before the introduction of MMT program in this prison. Among participants, 7% reported never having used illicit drugs in their lifetime, but 51% had used non-injecting illicit drugs, and as high as 42% reported having injected an illicit drug. Up to 79% (160/203) of all participants reported using drugs, and about 6% (12/203) reported drug injecting during their current incarceration term. Same-gender sexual practice during current incarceration term was reported by 2.5% (5/203) of all male prisoners. Comparison between injecting and non-injecting drug-using prisoners indicated that drug injectors had higher rates of previous incarcerations, commenced drug use at a younger age, were more likely to have used illicit drugs in the previous week, were more likely to have been treated by a physician for drug addiction, had higher rates of registration for methadone treatment inside prison, and were more likely to have been tested for HIV infection. These study findings provide a behavioral profile of prisoners in regard to drug-related harm and can be considered in any plan to introduce or improve provision of MMT in prisons in Iran or other countries with similar features.

show abstract

“…48 Despite evidence of major benefits of prison NSPs in the absence of significant negative consequences and ample documentation of injecting drug use in Australian prisons, repeated efforts to establish these facilities have proved unsuccessful. 49 Moreover, as in other settings, the success in changing injecting risk behaviour has not been matched by changes in sexual risk behaviour among IDUs in Australia. Harm reduction has had little impact on the sexual transmission of HIV among and from IDUs.…”

Section: Health Education Of Injecting Drug Usersmentioning

confidence: 99%

The effectiveness of harm reduction in preventing HIV among injecting drug users

Wodak¹,

Maher²

2010

NSW Public Health Bull.

View full text Add to dashboard Cite

show abstract

Interventions to reduce HIV transmission related to injecting drug use in prison

Cited by 177 publications

References 61 publications

Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa

Hepatitis C and associated risks in prisons: an integrative review Hepatite C e riscos associados em presídios: uma revisão integrativa

Patterns of Drug Use and HIV-Related Risk Behaviors among Incarcerated People in a Prison in Iran

The effectiveness of harm reduction in preventing HIV among injecting drug users

Contact Info

Product

Resources

About